How should we use calcineurin inhibitors in myasthenia gravis?

Hiroyuki Murai

研究成果: Contribution to journalReview article査読

抄録

Calcineurin inhibitors are approved for the treatment of myasthenia gravis in Japan. Utsugisawa et al. described the use of calcineurin inhibitors and outcomes of myasthenia gravis in Japan using the data of a multicenter survey. According to the result, they argue that calcineurin inhibitors should be given more aggressively to late-onset myasthenia gravis patients and early-stage disease.

本文言語英語
ページ(範囲)118-119
ページ数2
ジャーナルClinical and Experimental Neuroimmunology
6
2
DOI
出版ステータス出版済み - 5 1 2015

All Science Journal Classification (ASJC) codes

  • Neuroscience (miscellaneous)
  • Immunology
  • Immunology and Microbiology (miscellaneous)
  • Clinical Neurology

フィンガープリント 「How should we use calcineurin inhibitors in myasthenia gravis?」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル